Non-prescription drugs

Distinguish between prescription drugs, non prescription drugs, and controlled substances. 

Pre-approval required non-prescription drugs prescription drugs V, restricted products 7 7 7 7 V 7 7 ... 

The clinician must identify potential reversible causes of HF exacerbations including prescription and non-prescription drug therapies, dietary indiscretions, and medication nonadherence. Non-adherence with dietary restrictions or chronic... 

Perform a thorough medication history to determine whether the patient is receiving any prescription or non-prescription drugs that may cause or contribute to the development of an arrhythmia. 

At each visit, evaluate the pharmacotherapy regimen for appropriate drug choice and dose, non-prescription drug use, adverse effects, and use of potentially hepatotoxic medications. 

Obtain a thorough and accurate drug history, including the use of non-prescription drugs such as NSAIDs. 

A. P. Lemberger, in Handbook of Non-Prescription Drugs, American Pharmaceutical Association, Washington, DC, 1973, p. 161. 

M. Danish and S. Rosenbaum, Dosing considerations for non-prescription drugs in infants and children, Clin. Res. Regul. Affairs, 9, 89 (1992). 

Legal principles in the area of dietary supplements are not well established. Some believe that liability should be the same for dietary supplements as it is for prescription and pharmacist-recommended non-prescription drugs [55]. 

However, the situation most commonly recognized is that competition in the market of patented prescription drugs is insufficient to produce an optimum level of information or an optimum level of welfare, which makes it necessary to establish some form of regulation. However, price regulation in the markets of non-prescription drugs and drugs whose patent has expired lacks theoretical justification. 

Griffith, H. W. The Complete Guide to Prescription and Non-prescription Drugs, 2004 Ed. New York Berkley Publishing Group, 2003. 

Non-prescription drugs are defined as Non-narcotic medicines or drugs which may be sold without a prescription and which are prepackaged for use by the... 

Over the years, dissolution testing has expanded beyond ordinary tablets and capsules—first to extended-release and delayed-release (enteric-coated) articles, then to transder-mals, multivitamin and minerals products, and to Class Monographs for non-prescription drug combinations. (Note at the time, sustained-release products were being tested, unofficially, in the NF Rotating Bottle apparatus). 

Establishes national uniformity in the regulation of non-prescription drugs. 

Requires the label of a non-prescription drug to bear the quantity or the proportion of each active ingredient. 

FDA has stated that the FD C Act provides no authority for FDA to restrict distribution of a non-prescription drug to pharmacies. 

The adulteration and misbranding provisions of the statute itself are continually expanded by FDA regulations that impose additional requirements either for all non-prescription drugs or for... 

The non-prescription drug industry traded records inspection for national uniformity under the FDA Modernization Act of 1997, 111 Stat. 2296, 2374, 2375 (1997). 

---